IPP Bureau
CAPFIMS to provide opportunity for medical graduates and specialists to serve in the medical cadre of CAPFs
By IPP Bureau - March 11, 2024
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
Briefs: Zydus Lifesciences and Rainbow Children's Medicare
By IPP Bureau - March 11, 2024
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
North India’s first government homoeopathic college coming up in Kathua: Dr. Jitendra Singh
By IPP Bureau - March 11, 2024
The institution will be spread over an area of more than 8 acres
LVPEI observes World Glaucoma Week
By IPP Bureau - March 11, 2024
Vision loss due to Glaucoma can be prevented if it is detected and treated early
Women's integral role in India's US$ 5 trillion ambition
By IPP Bureau - March 11, 2024
Women emerge as the cornerstone of this monumental undertaking
Solara Active Pharma elevates Arun Kumar Baskaran to the post of CFO
By IPP Bureau - March 09, 2024
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
Jagsonpal Pharmaceuticals launches QueeZy-ER
By IPP Bureau - March 09, 2024
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
Venus Remedies obtains marketing authorizations for essential oncology drugs in Ukraine
By IPP Bureau - March 09, 2024
These approvals mark significant progress for Venus Remedies in expanding its market presence
Dishman Carbogen Amcis updates on USFDA inspection at its Bavla facility
By IPP Bureau - March 09, 2024
The inspection was concluded with few procedural observations
USFDA conducts inspection at Alembic Pharmaceuticals' Panelav oncology formulation facility
By IPP Bureau - March 09, 2024
The company will provide comprehensive response to USFDA for the observations
Remedium Lifecare to acquire manufacturing facility in Hyderabad
By IPP Bureau - March 08, 2024
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
India approves Rs. 10,300 crore for AI Mission
By IPP Bureau - March 08, 2024
The investment will catalyse various components of the IndiaAI Mission
Biomanufacturing and Bio-foundry will drive India’s future bioeconomy: Dr. Jitendra Singh
By IPP Bureau - March 07, 2024
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
EMA validates MAAs for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan in two types of cancer
By IPP Bureau - March 07, 2024
The validations confirm the completion of the applications and commence the scientific review process
Sakar's oncology unit receives EU GMP approval
By IPP Bureau - March 07, 2024
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
